Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies

Bowman, Robert L., Busque, Lambert, Levine, Ross L.·2018·Cell stem cell
DOI 10.1016/j.stem.2018.01.011

Cited by (454)

Items 301–400 of 454

  1. Ultralow-dose irradiation enables engraftment and intravital tracking of disease initiating niches in clonal hematopoiesis
    Kevin Lee, Wimeth M. Dissanayake, Melissa MacLiesh, Cih-Li Hong, Zi Yin, Yuko Kawano, Christina M. Kaszuba, Hiroki Kawano, Emily R. Quarato, Brian Marples et al. · 2024 · Scientific Reports
  2. Prognostic impact of TET2 mutations in patients with acute myeloid leukemia: HM-SCREEN-Japan 01 and 02 study
    Satoshi Iyama, SungGi Chi, Masashi Idogawa, Takayuki Ikezoe, Kentaro Fukushima, Yoshikazu Utsu, Junya Kanda, Goichi Yoshimoto, Takahiro Kobayashi, Naoko Hosono et al. · 2025 · Annals of Hematology
  3. Association of Pre‐Diagnostic Clonal Hematopoiesis of Indeterminate Potential With Prognosis Among Patients With Cancer
    Xinyuan Liu, Hans‐Olov Adami, Tove Wästerlid, Huiwen Xue, Maria Feychting, Karin Ekstrom Ekstroem Smedby, Fang Fang, Qianwei Liu · 2025 · American Journal of Hematology
  4. Diagnostic Challenge and Clinical Dilemma: The Long Reach of Clonal Hematopoiesis
    Afaf E.G. Osman, Jay L. Patel · 2021 · Clinical Chemistry
  5. Bone marrow niches in myelodysplastic syndromes
    Giovanna Tosato, Jingxin Feng, Hidetaka Ohnuki, Minji Sim · 2021 · Journal of Cancer Metastasis and Treatment
  6. Clonal hematopoiesis in clinical practice: walking a tightrope
    Francesco Tarantini, Cosimo Cumbo, Luisa Anelli, Antonella Zagaria, Nicoletta Coccaro, Giuseppina Tota, Giorgina Specchia, Pellegrino Musto, Francesco Albano · 2022 · Leukemia & lymphoma/Leukemia and lymphoma
  7. MAC-1 marks a quiescent and functionally superior HSC subset during regeneration
    Anna Rydström, Els Mansell, Valgarður Sigurðsson, Julia Sjöberg, Shamit Soneji, Kenichi Miharada, Jonas T. Larsson · 2023 · Stem Cell Reports
  8. Recent advances in understanding the impact of infection and inflammation on hematopoietic stem and progenitor cells
    Michael D. Milsom, Marieke A. G. Essers · 2023 · Cells and Development
  9. Unifying targeted therapy for leukemia in the era of PARP inhibition
    Liberalis Debraj Boila, Amitava Sengupta · 2023 · Experimental Hematology
  10. Regulators of clonal hematopoiesis and physiological consequences of this condition
    Eunbee Park, Megan A. Evans, Kenneth X. Walsh · 2023 · The Journal of Cardiovascular Aging
  11. Identification of Mutations in IDH1/2, DNMT3A, ASXL1 Genes of Genome Epigenetic Regulation and Their Co-Occurrence with FLT3, NPM1, RUNX1 Mutations in Acute Myeloid Leukemia
    Ekaterina Belotserkovskaya, Ekaterina Konstantinovna Zaikova, Alexey Petukhov, Oleg N. Demidov, Ksenia Levchuk, Irina Garmaevna Budaeva, Daniil Zaytsev, Yu.D. Rogovaya, Aleksina Alekseevna Shatilova, Konstantin V. Bogdanov et al. · 2021 · Clinical oncohematology
  12. Driving mosaicism: somatic variants in reference population databases and effect on variant interpretation in rare genetic disease
    Vladimir Avramović, S. Frederiksen, Marjana Brkić, Maja Tarailo‐Graovac · 2021 · Human Genomics
  13. Prelude and premise to the special issue: disruption of homeostasis-induced signaling and crosstalk in the carcinogenesis paradigm “Epistemology of the origin of cancer”
    Björn L.D.M. Brücher, Ijaz S. Jamall · 2019 · 4open
  14. Dynamic Clonal Hematopoiesis and Functional T-cell Immunity in a Super-centenarian
    Erik B. van den Akker, Stavros Makrodimitris, Marc Hulsman, Martijn H. Brugman, Tanja Nikolic, Ted Bradley, Quinten Waisfisz, Frank Baas, Marja E. Jakobs, Daphne de Jong et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  15. iPSC Models of Leukemia Come of Age
    Sergei R. Doulatov · 2023 · Blood Cancer Discovery
  16. Therapy-selected clonal hematopoiesis and its role in myeloid neoplasms
    Jacob Jahn, Benjamin T. Diamond, Jeffrey Hsu, Skye Montoya, Tulasigeri M. Totiger, Ola Landgren, Francesco Maura, Justin Taylor · 2023 · Leukemia Research
  17. Clonal Hematopoiesis in Nonmalignant Disease: Functional Consequences of Mutated Immune Cells by Clonal Hematopoiesis in the Diseased Tissue
    Youngil Koh, Isak W. Tengesdal, Siddhartha Jaiswal · 2025 · Annual Review of Pathology Mechanisms of Disease
  18. A compartmentalized inflammatory landscape and macrophage plasticity regulate Tet2 +/− -mediated clonal hematopoiesis
    Kevin Lee, Cih-Li Hong, Wimeth M. Dissanayake, Gulzada Kulzhanova, Alexander Noel Pfeffer, Haiyin Li, Senthil Sivakumar, Zi Yin, Emily R. Quarato, Lauren Benoodt et al. · 2026 · Blood
  19. A somatic mutation in moesin drives progression into acute myeloid leukemia
    Ouyang Yuan, Amol Sanjay Ugale, Tommaso De Marchi, Vimala Anthonydhason, Anna Konturek-Cieśla, Haixia Wan, Mohamed Eldeeb, Caroline Drabe, Maria Jassinskaja, Jenny Hansson et al. · 2022 · Science Advances
  20. Clonal hematopoiesis, inflammation, and cardiovascular disorders: a mitochondrial connection
    Francesco Pileri, Gioacchino Natoli · 2022 · Trends in Immunology
  21. Detection of Cancer Stem Cells in Normal and Dysplastic/Leukemic Human Blood
    Alessia De Stefano, Alessandra Cappellini, Irene Casalin, Stefania Paolini, Sarah Parisi, Maria Vittoria Marvi, Antonietta Fazio, Irene Neri, Foteini‐Dionysia Koufi, Stefano Ratti et al. · 2024 · Methods in molecular biology
  22. Loss of hematopoietic diversity with age
    Isabel Beerman · 2019 · Blood
  23. Acute and chronic leukemias
    Kristen Beth McCullough, Mrinal M. Patnaik · 2022 · Elsevier eBooks
  24. Non-neutral clonal selection and its potential role in mammalian germline stem cell dysfunction with advancing age
    Victor Stolzenbach, Dori C. Woods, Jonathan L. Tilly · 2022 · Frontiers in Cell and Developmental Biology
  25. Inherited heterozygous Fanconi anemia gene mutations in a therapy-related CMML patient with a rare NUP98-HOXC11 fusion: A case report
    Kefeng Shen, Meilan Zhang, Jiachen Wang, Wei Mu, Jin Wang, Chunyan Wang, Shugang Xing, Zhenya Hong, Min Xiao · 2022 · Frontiers in Oncology
  26. The etiology of clonal mosaicism in human aging and disease
    Sanne Massaar, Mathijs Arnoud Sanders · 2023 · Aging and Cancer
  27. Aberrant X chromosome skewing and acquired clonal hematopoiesis in adult-onset common variable immunodeficiency
    Gabriel K.Y. Wong, Sara Barmettler, James Heather, David G. Millar, Sarah A. Penny, Aarnoud P. Huissoon, Alex G Richter, Mark Cobbold · 2019 · JCI Insight
  28. What Plasma Can Tell Us When Tissue Cannot: A Case Report of Genomic Testing in mCRPC and Clinical Response to Treatment With the PARP Inhibitor Rucaparib
    Daniel Peter Petrylak, Simon Paul Watkins, Andrea Loehr · 2022 · Frontiers in Oncology
  29. Glioneuronal Growth Infiltrating Lumbosacral Nerve Roots Following Intrathecal Stem Cell Injections Highlighting Perils of Stem Cell Tourism
    Rahul H. Rahangdale, Sandeep Rana, Prarthana Prakash, Mohammad Ali, Mary Flaherty, Andrea S. Synowiec, Susan M. Baser, Thomas F. McNair Scott · 2019 · Movement Disorders Clinical Practice
  30. On fitness: how do mutations shape the biology of cancer?
    Ian J. Majewski · 2019 · Biochemical Society Transactions
  31. Leukemia’s Clonal Evolution in Development, Progression, and Relapse
    Jui Wan Loh, Hossein Khiabanian · 2019 · Current Stem Cell Reports
  32. Introductory Chapter: Advances in Hematologic Malignancies
    Gamal Abdul Hamid, Fadhel Hariri · 2019 · IntechOpen eBooks
  33. Why are cell populations maintained via multiple compartments?
    Flavia Feliciangeli, Hanan Dreiwi, Martín López‐García, Mario Castro, Carmen Molina-Parı́s, Grant Lythe · 2022 · Journal of The Royal Society Interface
  34. Clonal Origin in Normal Adults of All Blood Lineages and Circulating Hematopoietic Stem Cells
    Kai Wang, Zi Yan, Shouping Zhang, Boris Bartholdy, Connie J. Eaves, Eric E. Bouhassira · 2019 · Experimental Hematology
  35. Epigenetic control of commensal induced Th2 Responses and Intestinal immunopathology
    Kishan A. Sangani, Morgan E. Parker, Hope D. Anderson, Li Chen, Surya Prakash Pandey, Joseph F. Pierre, Marlies Meisel, Samantha J. Riesenfeld, Reinhard Hinterleitner, Bana Jabrì · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  36. Clinical progression of clonal hematopoiesis is determined by a combination of mutation timing, fitness, and clonal structure
    Eric Latorre Crespo, Neil Robertson, Esra Gozde Kosebent, Louise MacGillivray, Lee Murphy, Md Mesbah Uddin, Eric A. Whitsel, Michael C. Honigberg, Alexander G. Bick, Alex P. Reiner et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  37. An approach for developing a blood-based screening panel for lung cancer based on clonal hematopoietic mutations
    Ramu Anandakrishnan, Ryan Shahidi, Andrew Dai, Veneeth Antony, Ian J. Zyvoloski · 2024 · PLoS ONE
  38. The phenomenon of clonal hematopoiesis: etiology, classification and its prognostic role
    E. O. Kunevich, Mariia Mikhaleva, О. Б. Крысюк, Alexander N. Bogdanov, Anastasiia Zherniakova, Сергей Владимирович Волошин · 2025 · Oncohematology
  39. Impact of Clonal Hematopoiesis on Solid Tumor Progression Following Radiation Therapy
    Jacqueline J. Tao, Jeremy S. Setton, Pablo Sánchez Vela, Anton Mikhailovich Safonov, Elizabeth Anne Comen, Lior Zvi Braunstein, Jorge Sergio Reis-Filho, Nadeem Riaz, Simon N. Powell, Ross L. Levine et al. · 2025 · JCO Precision Oncology
  40. Cardiovascular Disease Meets Cancer: Exploring the Epidemiology in China and Homotherapy Targeting Intersectional Mechanisms
    Shihan Xiang, Yujie Shan, XU Shi-hong, Jing Wang, Meng Luo, Jiaojiao Zhou, Qishan Chen · 2025 · Advanced Science
  41. Early Driver, Late Bystander: Stage-Specific Roles of DNMT3A R882 Mutations Unveiled in Human AML
    Yubin Zhou, Yun Huang · 2026 · Cancer Discovery
  42. Dietary Compounds Drive Epigenetic Regulation and Modifications in Blood Cancer: A Critical Review
    Farhan Ikhtiar, Adil Jamal, Shumaila Kiran, Md. Belal Hossain · 2026 · Molecular Nutrition & Food Research
  43. The Evolution of Polyclonal Competition in Aging Hematopoiesis
    Nathaniel V. Mon Père, Francesco Terenzi, Benjamin Werner · 2026 · Cancer Discovery
  44. Clonal evolution characteristics and reduced dimension prognostic model for non-metastatic metachronous bilateral breast cancer
    Lingyu Li, Jiaxuan Li, Jiwei Jia, Hua He, Mingyang Li, Yan Xu, Qing Yu, Hanfei Guo, Hong Wang, Zheng Lv et al. · 2022 · Frontiers in Oncology
  45. Cardiovascular and oncological diseases — focus on modifiable risk factors and modern pathogenetic aspects
    Jurij I. Buziashvili, И. С. Стилиди, С.Т. Мацкеплишвили, Асымбекова Эльмира Уметовна, Тугеева Эльвина Фаатовна, Елена Владимировна Артамонова, Акилджонов Фирдавсджон Рустамджонович, Alier A. Rakhmanzhanov, Elena Zelikovna Golukhova · 2023 · Annals of the Russian academy of medical sciences
  46. Recent advances in the application of induced pluripotent stem cell technology to the study of myeloid malignancies
    Dharamveer Tatwavedi, Andrea Pellagatti, Jacqueline Boultwood · 2023 · Advances in Biological Regulation
  47. Clinical impact and characteristics of erythroid dysplasia in adult aplastic anaemia: Results from a multicentre registry
    Tomoya Maeda, Akira Matsuda, Junya Kanda, Hiroshi Kawabata, Takayuki Ishikawa, Kaoru Tohyama, Akira Kitanaka, Kayano Araseki, Kei Shimbo, Tomoko Hata et al. · 2024 · British Journal of Haematology
  48. Modification of the Antibiotic, Colistin, with Dextrin Causes Enhanced Cytotoxicity and Triggers Apoptosis in Myeloid Leukemia
    Siân Rizzo, Mathieu Varache, Edward John Sayers, Arwyn Tomos Jones, Alex Tonks, David Wayne Thomas, Elaine L. Ferguson · 2024 · International Journal of Nanomedicine
  49. A Single Centre Study of the Prevalence of Haematological Malignancies in the South-South Region of Nigeria
    Ishau Muhammad Dirisu, Efe Mobolaji Okuonghae, Augustine Onovuakpo Eguvbe · 2024 · Annals of Health Research (The Journal of the Medical and Dental Consultants Association of Nigeria OOUTH Sagamu Nigeria)
  50. Molecular insights and treatment innovations: Advancing outcomes in acute myeloid leukemia with myelodysplasia‑related changes (Review)
    Hong Qiu, Chaowei Zhang, Xiaochen Ma, Ying Li · 2025 · Oncology Reports
  51. Overexpression of the signaling coordinator GAB2 can play an important role in acute myeloid leukemia progression
    Michael H. Kramer, Stephanie N. Richardson, Yang Li, Tian-Kai Yin, Nichole M. Helton, Daniel R. George, Michelle Cai, S. M. Ramakrishnan, C. Katerndahl, Christopher A. Miller et al. · 2025 · Journal of Clinical Investigation
  52. Id1 promotes clonal hematopoiesis in mice with Tet2 loss of function
    Shweta Singh, Kristbjorn O. Gudmundsson, Tanmoy Sarkar, Brad L. Jakubison, Holly M. Morris, Sandra Sczerba Burkett, Baktiar O. Karim, Gary T. Pauly, Dina M. Sigano, Joel P. Schneider et al. · 2025 · Science Advances
  53. Therapy Response and Outcome Explained by Leukemia Cell of Origin
    Zhimin Gu, Kathryn E. Dickerson, Jian Xu · 2020 · Cancer Discovery
  54. Difference in gene mutation profile in patients with refractory/relapsed versus newly diagnosed acute myeloid leukemia based on targeted next-generation sequencing
    Mengzhen Wang, Ruiqi Wang, Hong Wang, Chongjian Chen, Jiayue Qin, Xiaoning Gao, Li Yu · 2021 · Leukemia & lymphoma/Leukemia and lymphoma
  55. Interaction between CASP8AP2 and ZEB2-CtBP2 Regulates the Expression of LEF1
    Chanjuan Wang, Ming-Zhu Jia, Liping Deng, Weijing Li, Qing Zhang, Tongjia Zhang, Shuyan Li, Lei Cui, Zhigang Li · 2022 · Pediatric Hematology and Oncology
  56. RETRACTED: In Vivo Monitoring of Polycythemia Vera Development Reveals Carbonic Anhydrase 1 as a Potent Therapeutic Target
    Shohei Murakami, Vilma Barroca, Leïla Perié, Anne Bravard, Jacqueline Bernardino-Sgherri, Amandine Tisserand, Caroline Devanand, Valérie Edmond, Aurélie Magniez, Sabrina Tenreira Bento et al. · 2022 · Blood Cancer Discovery · Retracted
  57. A new risk factor associated with cardiovascular disease: clonal hematopoiesis of indeterminate potential
    Xiongkai Yu, Ningjing Qian, Yaping Wang · 2023 · Molecular Biology Reports
  58. Murine double minute X plays a central role in leukemic transformation and may be a promising target for leukemia prevention strategies
    Koki Ueda · 2023 · Experimental Hematology
  59. Leukemic transformation during anti-tuberculosis treatment in aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome: A case report and review of literature
    Nuan-Nuan Xiu, Xiao-Dong Yang, Jia Ming Stella Xu, Bo Ju, Xiao-Yun Sun, Xi-Chen Zhao · 2023 · World Journal of Clinical Cases
  60. Development of a myelodysplastic/myeloproliferative neoplasm-unclassifiable in a patient with acute myeloid leukemia: a case report and literature review
    Meifang Zhao, Jingnan Sun, Shanshan Liu, Hongqiong Fan, Yu Fu, Yehui Tan, Sujun Gao · 2021 · Journal of International Medical Research
  61. Measures of Clonal Hematopoiesis: Are We Missing Something?
    Leonid V Bystrykh, Mirjam E. Belderbos · 2022 · Frontiers in Medicine
  62. Potential Pre‐Leukemic Mutations in PPM1D Confer Chemotherapy Resistance to Aged HSC Clones
    Michael D. Milsom · 2019 · HemaSphere
  63. Genetic landscape of acute myeloid leukemias with leukocytosis
    Ksenia Pekhova, Yulia Vladimirovna Sidorova, Nataliya A. Severina, О А Глинщикова, И. С. Февралева, Бидерман Белла Вениаминовна, Yulia A. Chabaeva, Sergei M. Kulikov, Irina Lukianova, A. I. Kashlakova et al. · 2023 · Oncohematology
  64. Application of mass cytometry to characterize hematopoietic stem cells in apheresis products of patients with hematological malignancies
    Carlos Agustín Villegas Valverde, Antonio Alfonso Bencomo‐Hernandez, Yandy Marx Castillo‐Aleman, Yendry Ventura‐Carmenate, Imilla Casado Hernández, Rene Antonio Rivero Jimenez · 2023 · Hematology Transfusion and Cell Therapy
  65. Can Ruxolitinib Crash TET2 - and IDH2 -Driven Clonal Hematopoiesis?
    Elmira Khabusheva, Margaret A. Goodell · 2024 · Cancer Discovery
  66. Evaluation of bone density, bone architecture, and body composition in children with β-thalassemia major after hematopoietic stem cell transplantation
    Wasmaa Khaled, Asmaa El-Kaffas, Amany Mahmoud Elbarky, Fatma Sharawy, Nahed Mohammed Hablas · 2024 · The Egyptian Journal of Haematology
  67. Induced pluripotent stem cell-based modelling of disease evolution in myeloid leukemia: MDS to AML
    Jacqueline Boultwood · 2025 · Advances in Biological Regulation
  68. Elucidating the risk factors and oncogene drivers of acute myeloid leukemia
    Daniel Ruben Akiola Sanya, Djamila Onésime · 2025 · Human Cell
  69. Clonal hematopoiesis of indeterminate potential and malignant neoplasms
    В. Е. Шевченко, Tatyana Kushnir, Margarita V. Gudkova, Natalia E. Arnotskaya · 2025 · Advances in molecular oncology
  70. Ph-chromosome-negative myeloproliferative neoplasms: clonal dynamics are the name of the game
    Mohammadamin Noorafrooz, Ramin Noorafrooz, Giovanni Barosi, Robert Peter Gale · 2026 · Blood Reviews
  71. Longitudinal Whole-Exome Sequencing Identifies Clonal Hematopoiesis and Genomic Heterogeneity as a Predictor of Treatment Outcome in Patients with Newly Diagnosed, Elderly Chronic Lymphocytic Leukemia
    Ho Cheol Jang, Ga‐Young Song, Hyeonjin Jeong, J. M. Byun, Jee Hyun Kong, Myung-won Lee, Won Sik Lee, J H Lee, Ho sup Lee, Ho‐Young Yhim et al. · 2026 · International Journal of Molecular Sciences
  72. Cohesin complex cooperates with PU.1 at super-enhancers to regulate the differentiation and identity of conventional dendritic cells
    Pallawi Choubey, Amit Kumar, Sreeparna Podder, Sunil K. Raghav, Kushagra Bansal · 2026 · Cell Reports
  73. The Clinical and Laboratory Features of Clonal Hematopoiesis of Indeterminate Potential
    Jay L. Patel · 2018 · Advances in Molecular Pathology
  74. Myelodysplastic Syndromes
    Jason Xiaojun Cheng, James W. Vardiman · 2020 · Springer eBooks
  75. Allogeneic hematopoietic stem cell transplantation: lessons learned by a molecular immunologist/transplant patient
    Stephen T. Smale · 2022 · Trends in Immunology
  76. In-depth understanding of higher-order genome architecture in orphan cancer
    Tianyi Ding, Jixing Zhang, Haowen Xu, Xiaoyu Zhang, Fan Yang, Yibing Shi, Yiran Bai, Jiaqi Yang, Chaoqun Chen, He Zhang · 2023 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  77. Vienna Cancer Stem Cell Club (VCSCC): 20 year jubilee and future perspectives
    Peter Valent, Irina Sadovnik, Barbara Peter, Daniel Ivanov, Axel Schulenburg, Emir Hadzijusufovic, Michael Willmann, Thomas Rülicke, Harald Herrmann, Werner Rabitsch et al. · 2023 · Expert Review of Hematology
  78. Colorimetric Barcoding to Track, Isolate, and Analyze Hematopoietic Stem Cell Clones
    Dorothee Bornhorst, Brandon J.F. Gheller, Leonard Ira Zon · 2023 · Methods in molecular biology
  79. Non-Random Selection of Cancer-Causing Mutations in Tissue-Specific Stem Cells Cause Cancer.
    Arnold J. Levine · 2020 · PubMed
  80. A Review of Molecular and Genetic Diagnostics of Myeloid Malignancies with Emphasis on Diagnostics in Bosnia and Herzegovina
    Amina Kurtović-Kozarić, Erna Islamagić, Adna Ašić, Lejla Mehinovic-Cavcic, Larisa Bešić, Hana Sahinbegovic, Hana Komic, Sabira Kurtovic, Lejla Burazerović · 2021 · Acta Medica Academica
  81. Bedeutung der klonalen Hämatopoese für hämatologische Neoplasien
    Katharina S. S. Götze, Claudia Lengerke · 2022 · Die Innere Medizin
  82. Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999
    Franck Rapaport, Kenneth Seier, Yaseswini Neelamraju, Duane C. Hassane, Timour Baslan, Daniel T. Gildea, Samuel Haddox, Tak Hong Lee, H. Moses Murdock, Caroline K. Sheridan et al. · 2022 · Blood Cancer Journal
  83. Recent Advances in Haematology
    Mohammad Mizanur Rahman · 2020 · Haematology Journal of Bangladesh
  84. Differential sensitivity to LINE 1-induced damage contributes to the expansion of Tet2-deficient HSCs upon chronic inflammatory stress
    Anne Stolz, Cheng Xuan, Christelle Freitas, Rabie Chelbi, Hassan Ait-Ougouram, David Fandrei, Mengliang Ye, Elisabeth Nelson, Claire Maillard, Mathieu Bohm et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  85. Proteostasis Stress Drives Stem Cell Aging, Clonal Hematopoiesis and Leukemia
    Fanny Zhou, Michelle K. Le, Helen C. Wang, Wei Yang, Huan‐You Wang, Arukshita Tiwari, Xinjian Cen, Mary Jean Sunshine, Jeffrey A. Magee, Robert A. J. Signer · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  86. Clonal Hematopoiesis of Indeterminate Potential as an Emerging Interdisciplinary Risk Factor in Alzheimer’s Disease: Current Evidence and Future Directions
    Kopp, Klara, Silva, Patricia, Damm, Frederik, Cosma, Nicoleta Carmen · 2026 · Biomedicines
  87. Trim24 in Normal & Malignant Hematopoiesis
    Justin Shaw · 2018 · Digital Commons-TMC (Texas Medical Center)
  88. A vérképzőőssejt-niche szerepe a hematológiai neopláziák iniciációjában és progressziójában
    Zsolt Matula, Gábor Mikala, S. Veronika Urbán, Istvan T. Valyi-Nagy, Ferenc Uher · 2018 · Hematológia–Transzfuziológia
  89. The Role of Mesenchymal Stromal Cells and Classical Dendritic Cells in the Maintenance and Regulation of the Bone Marrow Niche
    Jingzhu Zhang · 2018 · Open Scholarship Institutional Repository (Washington University in St. Louis)
  90. Relationship between disease biology and clinical phenotype in myeloproliferative neoplasms
    Jyoti Nangalia · 2019 · HemaSphere
  91. Klonale Hämatopoese – Teil 2
    Detlef Thomas Haase · 2019 · best practice onkologie
  92. Dynamic regulation of DNA methylation in human T-cell biology
    Antonio Lentini · 2019 · Linköping University medical dissertations
  93. Applied Genomics and Public Health Cancer Genomics
    P. Porcu, Gaurav Kumar, N. Chakravarti, N. Arora, A. Mishra, A. Binder, A. Ertel, P. Fortina · 2020 · Elsevier eBooks
  94. Overt and Masked Polycythemia Vera Within the Scope of Ph-Negative Myeloproliferative Diseases
    Z. V. Tratsevskaya, Alla Mikhailovna Kovrigina, Dmitry I. Chebоtarev, Anait Levonovna Melikyan, А О Абдуллаев, Andrey Borisovich Sudarikov · 2020 · Clinical oncohematology
  95. Physiologic and pathologic profiling of clonal variations
    Winghing Wong · 2020 · Open Scholarship Institutional Repository (Washington University in St. Louis)
  96. Longitudinal clonal architecture of acute myeloid leukemia with NPM1 driver insertion, early TET2 mutations and secondary e6a2 BCR-ABL1 rearrangement
    Maria Pilar Gallego Hernanz, Nathalie Sorel, Sabrina Bouyer, Déborah Desmier, Mélanie Chollet, Natacha Maillard, Françoise Brizard, Niels Moya, José Miguel Torregrosa Diaz, Xavier P Leleu et al. · 2020 · Leukemia & lymphoma/Leukemia and lymphoma
  97. A MASCOT for mosaic analysis
    Yan Yan, Tuomas Tammela · 2020 · Proceedings of the National Academy of Sciences
  98. State-Transition Analysis of Time-Sequential Gene Expression Identifies Critical Points That Predict Leukemia Development
    Russell C. Rockne, Sergio Branciamore, Jing Qi, David Eugene Frankhouser, Denis O’Meally, Wei-Kai Hua, Guerry Cook, Emily Carnahan, Lianjun Zhang, Ayelet Marom et al. · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  99. A view from the hospital window.
    Albert G. Richards · 1974 · PubMed Central
  100. Estudo citogenético e molecular de síndromes mielodisplásicas / leucemia mieloide aguda familiar
    Marcela Cavalcante de Andrade Silva · 2020